Trial intelligence / Profile preview

Adalimumab versus methotrexate versus placebo in moderate to severe chronic plaque psoriasis

2004-004602-25Phase 3Completed

Sponsor

Abbott Laboratories

Start

Mar 2005

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1